相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The roles of glucose metabolic reprogramming in chemo- and radio-resistance
Jinguan Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy
Valentina Condelli et al.
CELLS (2019)
Extracellular vesicles and energy metabolism
K. Goran Ronquist
CLINICA CHIMICA ACTA (2019)
LncRNA TUG1 affects cell viability by regulating glycolysis in osteosarcoma cells
Xiufu Han et al.
GENE (2018)
Long non-coding RNAs in thyroid cancer: Biological functions and clinical significance
Fang Sui et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Exosomics-A Review of Biophysics, Biology and Biochemistry of Exosomes With a Focus on Human Breast Milk
Carolina de la Torre Gomez et al.
FRONTIERS IN GENETICS (2018)
Metabolic Reprogramming in Thyroid Carcinoma
Raquel Guimaraes Coelho et al.
FRONTIERS IN ONCOLOGY (2018)
Role of long non-coding RNAs in glucose metabolism in cancer
Chunmei Fan et al.
MOLECULAR CANCER (2017)
Glycolysis-related protein expression in thyroid cancer
Ji Hae Nahm et al.
TUMOR BIOLOGY (2017)
Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets
Domenico Ciavardelli et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells
C. Subramanian et al.
NEOPLASIA (2017)
Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors
Katherine M. Byrd et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion
Peter T. White et al.
SURGERY (2016)
Exosome mediated communication within the tumor microenvironment
Lara Milane et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Triazole containing novobiocin and biphenyl amides as Hsp90 C-terminal inhibitors
Jinbo Zhao et al.
MEDCHEMCOMM (2014)
Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer
Francis Worden
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2014)
Novel C-Terminal Hsp90 Inhibitor for Head and Neck Squamous Cell Cancer (HNSCC) with in vivo Efficacy and Improved Toxicity Profiles Compared with Standard Agents
Stephanie M. Cohen et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic Cells
Shary N. Shelton et al.
MOLECULAR PHARMACOLOGY (2009)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
分享论文
